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CHAPTER 1  
INTRODUCTION AND LITERATURE REVIEW  
1.1 Introduction to the natural product syntheses 
 
Natural product synthesis, the art and science of constructing the molecules of nature 
in the laboratory, has been a most attractive area for organic researchers all around the 
world. The enthusiasm to mimic nature and to discover its secrets, by exploring efficient 
ways to synthesize novel and important bioactive natural products, pushes the scientists 
to develop new synthetic methodologies and to explore new chemical reactivity (1). 
 
A flagship of organic synthesis(1), natural product synthesis is an efficient tool to 
evaluate the power of existing synthetic methods and the driving force to develop 
efficient and novel synthetic methods and strategies. The limitless chemical diversity of 
the natural products provides a huge challenge for synthetic chemists to make these 
unique structures and cost-effectively in larger quantities to carry out further biological 
investigations and medical applications (2). 
 
As nature remains a source of “leading compounds”, natural product synthesis will 
continue to be the leading science with vast opportunities for new developments and 
discoveries. 
 
The advances in the drug design and structure-activity relationship studies have 
allowed modification of the structure of natural products to enhance their potency and 
improve their selectivity to attain better pharmacological properties (3). 
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1.2 Marine Natural Products 
The Oceans, with a wide variety of living organisms have been explored since 1943, 
are now considered to be a great source of potential drugs. The immense marine 
reservoir provides the natural products’ library with many active metabolites which can 
be an ideal resource for the discovery of new drugs.  
 
Vast and unique organic chemical structures have been observed in the extracts of 
marine organisms. Many of them have been shown to be promising candidates as anti-
cancer agent as well as anti-infective agent (4). Cytarabine (Ara C) is used efficiently in 
cancer chemotherapy, for the treatment of leukemia, and it was developed from marine 
origin natural products(5) (spongothymidine and spongouridine) (Figure 1). 
         
Figure 1 
   Sponges have proved to be the richest source of marine natural products with 
interesting biomedical potentials. Organic compounds synthesized by both sponges and 
microorganisms living within the sponge host were found to possess potent anticancer, 
antibiotic, antifungal, antiviral, antiparasitic, and antifouling activities (6) . 
 
   During the search for novel and new anti-cancer drugs, enormous work has been 
carried out in order to screen the crude extracts of marine organisms for biological 
activity. That research has led to many promising findings such as antitumor and/or 
cytotoxic activities. Further efforts have to be focused on translating these bioactivities 
into useful drugs by using effective pre-fractionation strategies, advanced identification 
techniques, and novel synthetic methods (7). 
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1.3 Lamellarins 
1.3.1 Isolation and Structure 
Lamellarins, a family of alkaloids bearing 3,4-diarylpyrrole unit, have been isolated 
from marine prosoblanch mollusks, ascidians, and sponges. The first isolation of 
Lamellarins (A, B, C, D) from Lamellaria sp., a prosobranch mollusk (Family 
Lamellariidae) was in 1985(8). Later, four additional analogues, lamellarins (E-H), were 
isolated and identified by Fenical and co. workers in 1988 (9). 
 
In 1993, Bowden’s group reported six new Lamellarins, Lamellarins (I-M) and the 
triacetate of lamellarin N, isolated from an Australian colonial ascidian Didemnum sp(10). 
In the following year, Capon and colleagues reported the first two lamellarins with 
unfused pyrrole ring, namely lamellarins O and P (11). The instability of both compounds 
prevented further biological studies and restricted the exploration of the bioactivity of 
this new class of lamellarins. One year later, two new stable members of this class, 
lamellarins Q and R, were reported by the same research group (12). Among them 
lamellarin O has shown a good potential as an effective cytotoxic agent for leukemia and 
lymphoma.    
 
The first optically active Lamellarin, Lamellarin S, was isolated in 1996 by Urban 
and Capon. Lamellarins displayed a positive optical rotation due to the atropisomerism, 
which is induced by the restricted rotation of the C-1 phenyl substituent around the    
C1-C11 bond(13).  
 
The alphabet continues with lamellarins T, U, V, W, and Y, which were isolated in 
their 20-sulfate form(14). Among the sulfated members of lamellarins family, Lamellarin 
α 20-sulfate was the best known metabolite. It was isolated from an unidentified ascidian 
collected from the Arabian Sea coast of India, and it was proved to be an interesting 
inhibitor of HIV-1 integrase(15). 
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So far more than 30 members belonging to the Lamellarins family and their related 
pyrrole-derived alkaloids have been isolated and identified (16). 
 
All the lamellarins and their related alkaloids have a general structure skeleton 
composed of pyrrole core with polyoxygenated aromatics on their periphery. Based on 
the nature of the pyrrole core, they can be classified into two main groups i.e; as a fused 
lamellarins (1) and (2) or unfused lamellarins (3). The former can be subdivided further 
into two main classes, (1) bearing a double bond on C5-C6 position or (2) a single bond 
at the same position. 
               
              1                                                         2                                            3 
Over 30 members belonging to the lamellarin family share the same pentacyclic core 
with structural variation coming from the hydroxy and methoxy substitution pattern of 
the aryl rings. In some cases, one of the phenols is sulfated, resulting in sulfated 
lamellarins with interesting biological activity (Table 1) (Table 2) (Figure 2). 
 
Other interesting structural features appear from the geometry of the molecule.     
The presence or absence of a double bond in C5-C6 position results in planar or         
nonplanar pentacyclic chromophore (6H-[1]benzopyrano[4,3:4,5]pyrrolo[2,1-
α]isoquinolin-one). The aromatic ring linked to the C1 position is disposed orthogonally 
to the pentacyclic system, and the restricted rotation around the C1-C11 bond induces an 
atropisomerism whose energy barrier depends on the substitution pattern of the 
molecule. 
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Lamellarin R1 R2 R3 R4 R5 R6 R7 X 
A OH OMe OH OMe OMe OMe OMe OH 
C OH OMe OH OMe OMe OMe OMe H 
E OH OMe OMe OH OMe OMe OH H 
F OH OMe OMe OMe OMe OMe OH H 
G OMe OH OMe OH OMe OH H H 
I OH OMe OMe OMe OMe OMe OMe H 
J OH OMe OMe OMe OMe OH H H 
K OH OMe OH OMe OMe OMe OH H 
L OH OMe OMe OH OMe OH H H 
S OH OH OH OH OMe OH H H 
T OH OMe OMe OH OMe OMe OMe H 
U OH OMe OMe OH OMe OMe H H 
V OH OMe OMe OH OMe OMe OMe OH 
Y OH OMe OMe OH OH OMe H H 
Z OMe OH OH OH OMe OH H H 
β OH OH OMe OH OH OH H H 
γ OH OMe H OMe OMe OMe OH H 
χ OAc OMe OAc OMe OMe OAc H H 
Table 1 
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N
O
R3
R4
R1
R2
O
R7
R6
R5
 
Lamellarin R1 R2 R3 R4 R5 R6 R7 
B OH OCH3 OH OCH3 OCH3 OCH3 OCH3 
D OH OCH3 OH OCH3 OCH3 OH H 
H OH OH OH OH OH OH H 
M OH OCH3 OH OCH3 OCH3 OCH3 OH 
N OH OCH3 OCH3 OH OCH3 OH H 
W OH OCH3 OCH3 OH OCH3 OCH3 OCH3 
X OH OCH3 OCH3 OH OCH3 OCH3 H 
α20-sulfate SO3Na OCH3 OCH3 OH OCH3 OCH3 H 
Є OH OMe OMe OMe OMe OMe OH 
ζ OH OMe OMe OMe OMe OMe OMe 
η OH OMe OMe OMe OMe OMe H 
Φ OAc OMe OAc OMe OAc OMe OMe 
Table 2 
 
R = 
 
H 
 
 
Figure 2 
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1.3.2 Biological Activities 
 
Lamellarins exhibit a wide range of interesting and significant biological activity, 
including cytotoxicity and antitumor activity, multidrug resistance (MDR), HIV-1 
integrase inhibition, antibiotic activity, human aldose reductase (h-ALR2) inhibition, cell 
division inhibition, immunomodulatory activity, antioxidant activity and feeding 
deterrence (3). 
 
Most of Lamellarins have been found to be cytotoxic to a wide range of cancer cell 
lines(18). Among them Lamellarin D has potent cytotoxic activity against various tumor 
cells, especially human prostate cancer cells ( DU-145, LNCaP) and leukemia cells 
(K562, P388) (18). The study shows that Lamellarin D is a potent inhibitor of DNA 
topoisomerase I, with cytotoxic action that is fully maintained in multidrug resistance 
cell lines(20). Lamellarin O also proved to be an effective cytotoxic agent for leukemia 
and lymphoma, inhibiting (L1210) lymphocytic leukemia DNA synthesis with less 
effect on RNA and protein synthesis(21). 
 
Some Lamellarins were found to be nontoxic inhibitors of multidrug resistance 
(MDR) in various cancer cell lines, which may improve the effectiveness of a wide 
variety of anticancer drugs. Quesada and his co-workers(22),(23) have demonstrated that 
Lamellarins K and I not only exhibit potent cytotoxic activity in vitro against MDR 
tumor cell lines but also reverse MDR at noncytotoxic concentrations by inhibiting the 
P-glycoprotein-mediated drug efflux at nontoxic doses. 
 
Lamellarins with dihydroisoquinoline framework (1), which bear a sulfate group, 
have shown impressive activity as inhibitors of the HIV-1 integrase enzyme (a 
promising target for the treatment of acquired immune deficiency syndrome “AIDS”). 
Faulkner and coworkers reported that Lamellarin α-20 sulfate is a selective inhibitor of 
HIV-1 integrase both in vitro and in vivo (15),(24). 
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1.3.3 Structure-Activity Relationship 
Structure-activity relationship (SAR) is a science that explains the source of activity 
and identifies the pharmacophore in many biologically active compounds. Thus it 
eventually leads to the design of new molecules that can mimic nature and potentially 
provide drugs for the treatment of diseases. 
 
The SAR study of Lamellarin D (25) has revealed that double bond at C5-C6 is an  
essential element for the antiatopoisomerase I activity. Furthermore the hydroxyl groups 
at C8, C14, and C20 were proved to be important structural requirements for cytotoxic 
activity and DNA-topoisomerase I inhibition.  
The aforementioned conclusions were confirmed by synthesizing different 
derivatives of Lamellarins D (4) and testing their biological activities. The importance of 
the hydroxyl group in specific positions was confirmed by acylation of these groups with 
various carboxylic acids. This considerably reduced the potency, whereas the amino 
acids derivatives, which preserved the hydrogen bonding capacity at these sites, afforded 
potent compounds (25) ,(26) . 
 
An SAR study was also performed on Lamellarin α20-sulfate (5) (27). It demonstrated 
that the presence of sulfate on the periphery of the compound can greatly influence 
selectivity in HIV-1 integrase inhibition.  
                                                                
4                                                                                                   5 
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CHAPTER 2  
Synthetic routes to Lamellarins and related natural products 
The Lamellarins and related pyrrole-derived alkaloids have attracted a lot of interest 
among synthesis researchers, due to their interesting biological activity coupled with the 
scarcity of these materials among natural sources.  
In order to synthesize such compounds, several synthetic approaches have been tried. 
These can be classified into two main categories based on the construction of the pyrrole 
ring. In the first approach, the formation of pyrrole core is accessed at a later stage of 
synthesis, and the highly functionalized precursors into the pyrrole core of the targets 
were assembled by means of intramolecular cycloaddition(28),(29),(30),(31),(32), azadiene 
Diels-Alder cycloaddition(33), oxidative dimerization(34),(35), or double-barreled Heck 
cyclization(36) (Figure 3). 
 
Figure 3 
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In the second approach, an intact pyrrole core is elaborated, but this process faces 
difficulties in functionalizing the pyrrole ring in the regiocontrolled fashion. It is 
therefore less explored (Figure 4). 
 
 
                                      
 
                                           
N
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O
O
5
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Figure 4 
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2.1 Late stage pyrrole formation approaches  
2.1.1 Biomimetic synthesis (Steglich approach) 
 
 The first biomimetic synthesis of Lamellarins was accomplished by Steglich and his 
co-workers in 1997(37). They synthesized Lamellarin G trimethyl ether from arylpyruvic 
acids by two consecutive oxidative reactions. The first reaction included the oxidative 
coupling of two arylpyruvic acids, followed by condensation with a suitable 2-
arylethylamine. The second oxidative reaction was between an aryl ring and carboxylic 
acid to give a lactone ring, which was in turn transformed to the isoquinoline framework 
by intramolecular Heck-type reaction leading to the final product (Figure 5). 
 
 
Figure 5 
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To access a nonsymmetrical Lamellarin molecule such as Lamellarin L, two 
different arylpyruvic acid ester units were employed (38). Additional precautions were 
applied to attain the desired structure, including (a) the prior formation of one of the 
arylpyruvic acid units as the α-halo compound, and (b) the use of two different esters of 
arylpyruvic acid (Figure 6). 
 
 
Figure 6 
 
Ester differentiation was accomplished by using methyl and ethyl esters, which can 
be cleaved selectively by using different reagents. 
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2.1.2 Hinsberg-type pyrrole synthesis (Iwao approach) 
Ishibashi and Iwao have reported a novel synthetic method for the preparation of 
3,4-diarylpyrrole unit to accomplish the total synthesis of Lamellarin G trimethyl ether 
(38), D, L and Lamellarin N(40). The proposed method was developed by using Hinsberg-
type pyrrole synthesis (Figure 7), followed by a palladium-catalyzed Suzuki cross-
coupling reaction of the 3,4-dihydroxypyrrole bis-triflate derivatives as key reactions. 
 
Figure 7 
The reported method was flexible enough to be applied for the synthesis of different 
Lamellarins, since the preparation of bis-triflates intermediate allows the coupling of 
different substituted phenylboronic acids. An interesting feature of this reaction is that it 
can be used for the preparation of nonsymmetrical Lamellarins by controlling the 
coupling conditions to get a mono-arylated intermediate, which in turn can be further 
coupled with a different substituted-arylboronic acid (Figure 8). 
 
Figure 8 
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2.1.3 Vinylogous Iminium Chemistry (Gupton approach) 
Vinylogous iminium ion chemistry was also utilized for the synthesis of Lamellarins 
and their related natural products(41),(42). Total syntheses of Lamellarin O dimethyl ether 
and lukianol A have been accomplished in a regiocontrolled fashion. In this way, the key 
intermediate (Furstner intermediate) was accessed in just three steps: (a) conversion of 
appropriate ketone to vinylogous amide; (b) transformation of this amide into 
chloropropeniminim salt; (c) condensation with glycine methyl ester hydrochloride 
under basic conditions(43) (Figure 9). 
 
 
 
                                       
Figure 9 
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2.1.4 Cycloaddition of Methylisocyanoacetate with α,β-unsaturated 
nitriles (Bullington approach) 
The Bullington research group in 2002 (43) developed a very efficient and concise 
synthesis of Furstner intermediate by using a 2+3 cycloaddition reaction of    α,β-
unsaturated nitriles with methyl isocyanoacetate (Figure 10). 
 
 
Figure 10 
 
The ease of preparation of α,β-unsaturated nitriles, by condensation of benzyl nitriles 
with aromatic aldehydes under basic conditions, allowed the incorporation of various 
aromatic groups into the pyrrole ring by reacting electron-deficient α,β-unsaturated 
nitriles with methyl isocyanoacetate, which in turn has permitted the control of 
regiochemistry of the final product. 
 
Using this method, Bullington and his colleagues reported the total synthesis of 
Ningalin B in only three steps giving 51% overall yield. 
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2.2 Functionalization of Pyrrole ring 
The second methodology to synthesize the Lamellarins framework is to begin with 
an intact pyrrole ring, and then to functionalize it. The challenge here is to establish a 
reliable method for regioselective functionalization of the pyrrole. Most attempts in this 
strategy include the application of cross-coupling chemistry on halogenated pyrrole. 
 
2.2.1  Double cross-couplings (Banwell / Iwao approaches) 
In the cross-coupling approach(45) the key synthesis step involves the Stille, Suzuki 
or Negishi cross-coupling reaction of readily available pyrrole 2-carboxylic acid 
derivatives with the appropriate aryl stannane, boronic acid or iodide, catalyzed by 
palladium metal. 
 
The dibromo pyrrole 2-carboxylic acid derivative was easily accessed from pyrrole 
triisopropylsilyl derivative by reacting it with N-bromosuccinimide (NBS) in THF (45). 
 
 
 
 
Lithium exchange of the tribromo derivative with PhLi, followed by quenching with 
acid chloride, afforded the key intermediate, which was coupled with the appropriate 
aryl stannane or aryl boronic acid to obtain a symmetrically arylated Furstner 
intermediate (Figure 11). 
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Figure 11 
The limitation of this strategy was evident when it was applied to synthesize 
differentially the di-arylated pyrroles, since the reported cross-coupling reactions could 
not be controlled to get mono-arylated pyrroles. This drawback was overcome by 
regioselective lithiation, followed by transmetallation and the Negishi cross-coupling 
reaction with aryl iodide (Figure 12). 
 
 
Figure 12 
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An interesting modification of the previous strategy utilized the attachment of               
p-toluenesulfonyl group on nitrogen, being an activated and directing group, to prepare  
3,4-dibromo-N-(p-toluenesulfonyl) pyrrole via direct bromination(46)  (Figure 13). 
 
 
Figure 13 
The results indicated that N-benzenesulfonyl-3,4-dibromopyrrole is far superior to 
3,4-dibromo-N-triisopropylsilylpyrrole as a substrate, at least in Suzukie-Miyaura cross-
coupling. The electron-withdrawing N-benzenesulfonyl group facilitates the initial 
oxidative insertion of C-Br bonds to Pd(0) and, as a consequence, it promotes an overall 
cross-coupling reaction cleanly to get the mono-arylated pyrroles with high 
regioselectivity (Figure 14). 
 
 
Figure 14 
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2.2.2 Heck/Suzuki couplings (Alvarez approach) 
In 2005, Alvarez and colleagues adopted the Heck coupling reaction as a key 
reaction to synthesize a Lamellarin skeleton(47). Alkylation of pyrrole ester with tosylate 
derivatives, followed by the Heck reaction, produced a dihydroisoquinoline pyrrole 
derivative, which could be monobrominated at pyrrole C-4 position or dibrominated at 
C-4 and C-5 positions, followed by coupling with aryl boronic acids (Figure 15). 
 
 
Figure 15 
 
The reported synthesis was the most versatile and flexible way to prepare different 
substituted Lamellarins from the intact pyrrole core. 
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CHAPTER 3  
Objectives and work plan 
3.1 Importance of the proposed research 
Huge efforts have been made in recent decades to discover potent drugs for cancer 
treatment. Biochemists, associated with medicinal and synthetic chemists, have tried to 
exploit the diversity of natural products available from marine sources. 
 
The objective of this study was to achieve the first total synthesis of two different 
marine natural products, which were isolated from sponges and have proved to be 
potential anticancer agents. The two different alkaloids, Neolamellarin and Aplysamine 
6, were chosen due to their potent bioactivity as inhibitors of different anticancer targets.  
 
3.1.1 Neolamellarin as HIF-1 inhibitor 
 
In search of potent and selective small-molecule HIF-1 inhibitors taking advantage 
of the vast biochemical diversity afforded by natural products, the NCl Open Repository 
of marine invertebrates and algae lipid extracts. The biological activity was evaluated for 
HIF-1 inhibitory activity in a T47D human breast tumor cell-based reported assay. The 
crude extract of the sponge Dendrilla nigra (Aplysillidate) inhibited the hypoxia-induced 
HIF-1 activation (81% inhibition at 5 μg.ml-1) (47). Bioassay-guided chromatographic 
separation of the   D.nigra extract yielded four new Lamellarin-like phenolic pyrroles 
neolamellarins: neolamellarin A (6), neolamellarin B (7), 5-hydroxyneolamellarin C (8), 
and 7-hydroxyneolamellarin D (9), which bore structural features similar to lamellarin O 
(10) (47), originally isolated from the Australian sponge D. cacto s (10) ( Figure 16). 
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The effects of (6-9) on HIF-1 activity in a T47D cell-based reporter assay revealed 
that compound (9), being the most active, inhibited the hypoxia (1% O2)-induced HIF-1 
activation with an IC50 value of 1.9 μM. At the highest concentration (10 μM), the 
percentage inhibition exerted by (6-9) on HIF-1 activation was 26% (6), 23% (7), 22% 
(8), and 98% (9), respectively (47). Moreover compound (9) decreased the induction of 
secreted vascular endothelial growth factor (VEGF) protein, one of the most studied 
HIF-1 regulated target genes and a key factor that promotes tumor angiogenesis, in 
T47D cells by hypoxia (1% O2) and in 1,10-phenanthroline (10 μM) by 87% and 33%, 
respectively(35). 
 
 
Figure 16 
 
The limited quantity of (9) hindered the studies from elaborating the mechanism of 
action studies and further investigation of its potential as a molecular-targeted antitumor 
agent. There was a growing need to develop a synthetic way to access these targets, in 
order to conduct more extensive pharmacological studies of them.  
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3.1.2 Aplysamine 6 as inhibitor of (Icmt) anticancer target 
The C-terminal isoprenylcysteine motif of the CaaX proteins targets a variety of 
eukaryotic proteins to a series of post-translational modifications which are important 
for their localization and function.(49),(50) To initiate the processing, the protein 
farnesyltransferase, or the protein geranyl geranyltranferase type I, catalyze the covalent 
attachment of a 15-carbon farnesyl or a 20-carbon geranylgeranyl lipid to the cysteine of 
the CaaX motif.(51) After prenylation and followed by removal of three C-terminal amino 
acids, the C-terminal isoprenylcysteine is methylated by isoprenylcysteine carboxy 
methyltransferase (Icmt).(52) 
 
Proteins that terminate in a CaaX motif regulate a number of important pathways in 
oncogenesis. The most thoroughly studied example is the central role of the Ras family 
of proteins in the growth factor activation of the MAP kinase signaling cascade, In 
addition, many cancers contain alterations upstream of Ras, and the resultant 
hyperactivation of Ras is thought to contribute to tumorigenesis in these cancers as well 
(52). Recent studies using the genetic disruption of Icmt revealed that Ras proteins are 
significantly mislocalized, and tumorigenesis is markedly impaired, in cells that lack 
Icmt.(53) 
 
With emerging evidence for the importance of Icmt-catalyzed CaaX protein 
methylation in oncogenesis, there is a growing need for specific pharmacological agents 
to target this process. The development of Icmt inhibitors is a new way to find 
anticancer drugs.(54) In order to discover new Icmt inhibitors, bioassay-directed 
purification of extracts of the sponge Pseudoceratina sp (Pseudoceratinidae) produced a 
new bromotyrosine derivative, aplysamine 6 (11). (54) Aplysamine 6 contains one 
bromotyrosine unit and one bromomethoxycinnamoyl unit. It shows inhibition of Icmt 
with an IC50 of 14 μM (assay performed in duplicate on four independent days), and it is 
considered a new addition to the small list of inhibitors of Icmt. (54). 
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We aimed to accomplish the first total synthesis of Aplysamine 6 (11). 
 
 
11 
3.2 Objectives 
We aimed to adopt a facile synthetic approach to synthesize Neolamellarins A (6) 
and Aplysamine 6 (11) by utilizing very common starting materials available in-house. 
Our objectives were: 
 
1 – To study different approaches towards the syntheses of 3,4-diaryl pyrrole by 
utilizing a pyrrole ring formation strategy. 
 
2 – To optimize the demanding step of N-acylation of the pyrrole ring, in order to 
access the high functionalize intermediates and to accomplish the total synthesis of 
Neolamellarin A. 
 
3 – To develop a cost-effective and easy-to-exercise  synthetic pathway to achieve 
the first total synthesis of Aplysamine 6. 
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3.3 Methodology and the work plan 
3.3.1 Synthesis of Neolamellarin A 
To synthesize neolamellarin A the key step of our strategy centered on the base-
mediated cyclization, followed by three steps (decarboxylation, alkylation and 
deprotection) to attain the target compounds. 
The first part of this project was to prepare the key intermediate (12), which will be 
synthesized by three operations (alkylation, removal of benzyl group, and subsequent 
acetylation) as described in Figure 17. 
                                                                                                   12 
                                                                               Figure 17 
Parallel to that, another key segment, the dione (13), was required to accomplish the 
target compounds, and it was to be synthesized according to the literature (54)(Figure 18). 
 
                        13 
                                                                                         Figure 18 
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Later, the base-induced coupling of intermediates (12) and (13) allowed access to the 
pyrrole core advanced intermediate (19), which was converted to an intermediate (20) by 
hydrolysis and decarboxylation. The advanced intermediate (20) would in turn be 
subjected to amidation with intermediate (41) to attain (44), followed by demethylation 
to get the final target compound (Figure 19). 
 
 
                                                                              Figure 19 
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3.3.2 Synthesis of Aplysamine 6 
 
Aplysamine 6 will be prepared from highly functionalized key intermediates, amine 
(56) and acid (46). 
 
Intermediate (56) in turn will be prepared from 4-hydroxybenzaldehyde (48) by 
bromination, followed by the Henry reaction and reduction of the double bond.  
 
                        
                                               
                                                48                                                               56 
 
The acid intermediate (46) will be prepared by the conversion of p-anisaldehyde (21) 
to the known bromobenzaldehyde (47), followed by Doebner–Knoevenagel 
condensation with malonic acid to afford the cinnamic acid (46). 
 
 
            21                                             47                                                            46 
 
 
Once the cinnamic acid (46) is in hand, it will be converted into an acid chloride 
derivative (61), which will be condensed with amine (56) to achieve the advanced 
intermediate (62). 
HO
Br
Br
NH2.HBr
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The advanced intermediate (62) will be ultimately advanced to the target compound 
Aplysamine 6 (11). 
 
                     
                                                                                                                (62)   
 
 
 
 
 
 
 
 
 
                                           (11) 
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CHAPTER 4  
Results and Discussions  
4.1 Synthesis of Neolamellarin A 
In order to achieve the total synthesis of Neolamellarin A, the pyrrole subunit of the 
compound was synthesized by adopting different approaches as outlined in (Figure 20). 
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The other segment of the compound, in form of acid chloride derivative, was 
attached to the pyrrole core by means of N-acylation reaction, followed by deprotection 
to get the final target compound. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OCH3O
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4.1.1 Synthesis of 3,4-diaryl pyrrole 
4.1.1.1 Hinsberg-type pyrrole synthesis 
 
Formation of pyrrole ring, the key step in our synthesis approach, was accessed by 
Hinsberg-type condensation of the iminodiacetates (12) with Dion (13).  
 
                  
                                    12                                                                                        13                                                                  
In order to synthesize intermediate (12), the alkylation of acetamide or benzamide 
were proved to be unsatisfactory resulting in a mixture of monoalkylated and dialkylated 
products.  
R NH2
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This problem was overcome by developing an alternative procedure as outlined in 
Scheme 1. Acetylation of glycine (14) with acetic anhydride gave the corresponding 
acetyl-glycine (15), which in turn was esterificated by the action of thionyl chloride in 
MeOH. 
             
              14                                                        15                                                                16                    
Scheme 1 
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The N-alkylation of the intermediate (16) with methyl 2-acetamidoacetate in DMF, 
by using sodium hydride as a base, produced the desired intermediate (12) in an 
excellent overall yield (90%). 
 
   
                          16                                                                                            12 
The other key intermediate, the dione 3,3′-dimethoxybenzyl (18), was prepared by a 
standard benzoin condensation reaction, using thiamine or potassium cyanide as a 
catalyst affording 2-hydroxy-1,2-bis(4-methoxyphenyl)ethanone (17), which was 
oxidized by CuSO4 in pyridine to attain the desired dion (18) with a 66% overall yield.  
 
                                           
                                                   17                                                                    18                                                  
 
The base-induced Hinsberg-type condensation of the N-acetyliminodiacetate (12) 
with 3,3′-dimethoxybenzyl (13) was attempted by using sodium methoxide as a base in 
refluxing methanol to get the acid intermediate (19), which was purified by using acid-
base extraction, and then recrystallized from methanol-water (1:1) to get the product as a 
white needle solid. 
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19
 
 
          
Finally, decarboxylation of the acid intermediate (19) was attempted by using 
ethanol amine at elevated temperature according to the literature precedent (56), which 
was proved to be low-yielding. 
 
 
                                      19                                                                                        20 
Thus, the overall sequence for synthesizing the pyrrole (20) by Hinsberg-type 
condensation required several reaction steps coupled with low yields. This suggested a 
need to revise and redesign the strategy to access the pyrrole (20). 
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The reaction mechanism for the formation of pyrrole intermediate (20) is believed to 
be as below (Figure 21). 
 
 
 
 
 
 
 
 
 
                         
 
Figure 21 
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4.1.1.2 Arylpyruvic acid approach  
In our second attempt to synthesize the intermediate (20) we adopted Steglich’s 
approach for pyrrole synthesis as documented in the literature(37). We were thus required 
to synthesize the corresponding arylpyruvic acid (23), which in turn was constructed 
from p-anisaldehyde (21) according to the literature procedures (56). The condensation of 
acetyl-glycine (15) with p-anisaldehyde (21) in acetic anhydride, by using  sodium 
acetate as a base, gave intermediate (22), which was subjected to acid hydrolysis to 
obtain the derived (4-methoxyphenyl) pyruvic acid (23) with a 65% overall yield. 
 
                   21                                         15                                                                        22 
                                               
       23 
The conversion of arylpyruvic acid to the corresponding methyl ester (24) was 
achieved in DMF at a low temperature by using DBU as a base. 
     
                                                                                                    24 
The α-keto ester “3-(4-hydroxyphenyl) pyruvat” (24) was proved to be very unstable 
and to decomposes readily at room temperature. 
 
35 
 
 
 
Base-mediated coupling of two 3-phenylpyruvate fragments, by treating them with 
I2, NaOMe in methanol and then adding concentrated aqueous NH3, gave no desired 
product, even by heating for 4 hours. 
 
      
 
 
Different attempts, including the use of sodium bis(trimethyl silyl) amide as a base, 
were unsuccessful. 
The failure of the aforementioned approach was attributed to the formation of the 
enol-form (25) of the ketone (24). 
 
         24                                                                            25 
The mechanism of condensation of (23) is believed to be initiated by the attack of 
enolate on I2 to generate the intermediate (26), which undergoes self-condensation with 
another enolate of (24). 
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Finally, addition of ammonia led to the cyclization and formation of the pyrrole ring. 
 
 
                                                                               Figure 22 
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4.1.1.3 Vinylogous amide approach for pyrrole synthesis 
 
As an alternative approach, we adopted vinylogous iminium chemistry to synthesize 
the desired pyrrole (20). 
 
The synthesis pathway was commenced by the preparation of vinylogous amide 
(32), which in turn was synthesized from anisol (30) in two steps. First, the anisol (30) 
was acylated with 4-methoxyphenyl acetic acid (29) (57) in the presence of trifluoroacetic 
anhydride and phosphoric acid to generate desoxyanisoin (28), giving an excellent yield 
(98%). Second, the desoxyanisoin was condensed with N,N-dimethylformamide 
dimethyl acetal (31) in refluxing toluene. 
 
 
      
                         29                                        30 
 
                                  
28                                                                                                          32 
In order to get the desired key pyrrole intermediate (20), we required to synthesize 
dimethyl aminomalonate hydrochloride (34) which was to be coupled with the 
intermediate (32). Thus, the dimethyl malonate (33) was treated with sodium nitrite in 
acetic acid, followed by hydrogenation in methanolic solution of HCl using Pd/C as a 
catalyst to get the hydrochloride salt (34). 
H3PO4
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The condensation of the two key intermediates, vinylogous amide (32) and dimethyl 
aminomalonate hydrochloride (34) finally led us to the formation of the desired pyrrole 
core. The condensation of vinylogous amide (32) with dimethyl amino malonate (34) 
was carried out in acetic acid at a high concentration, followed by intramolecular ring 
closure of the proposed intermediate (35) and the loss of the methoxycarbonyl moiety by 
refluxing in acetic acid overnight (58). 
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The proposed way provided an easy access to the intermediate (36) and it gave an 
excellent yield. In order to transform it to the desired pyrrole intermediate (20), we 
required two further steps: ester hydrolysis and subsequent decarboxylation.  
 
 
                                                                                                  
 
For this purpose, ester (36) was hydrolyzed by LiOH to afford the corresponding 
acid (37) with a very good yield (98%). The decarboxylation of the acid derivative (37) 
was realized by using trifluoroacetic acid in CH2Cl2 at room temperature, which allowed 
us to access the key intermediate (20) in a high yield (98%) 
 
The advantages of the revised approach can be summarized as follows. 
1 - It provides an efficient way to prepare the pyrrole core in two steps in high overall 
yield (60%). 
2 – Since the synthesis goes through unsymmetrical intermediate, tracing the formation 
of pyrrole (20) can be easily elucidated by NMR. 
 
  
(20)
(37) 
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The reaction mechanism for the formation of pyrrole ester intermediate (36) is believed 
to be the following (Figure 23). 
 
 
 
 
 
 
 
                                                 
                                               
                                                                            
                                                                        Figure 23 
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4.1.2  Synthesis of Neolamellarin A 
After preparing the key intermediate (20), we next focused on the synthesis of the 
corresponding acids which was to be coupled with intermediate (20) in order to 
accomplish the synthesis of neolamellarin A. 
4.1.2.1 Synthesis of 4-methoxyphenylacetic acid 
4-Methoxyphenylacetic acid (41) was prepared in three steps by the reduction of     
p-anisaldehyde (21) with sodium borohydride followed by conversion of the alcohol 
(38) to the corresponding chloride (39) by thionyl chloride. The reaction of NaCN with 
chloride (39) in DMF produced cyanide (40), which was subjected to acid hydrolysis to 
obtain the desired acid (41). 
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                         41 
4.1.2.2 Synthesis of 4-methoxyphenyl oxoacetic acid 
The α-keto acid (43) was synthesized by the Henry reaction of nitromethane with                 
p-anisaldehyde (21) to obtain an adduct (42), which was oxidized with copper acetate 
refluxing in a mixture CH3COOH:CH3OH (1:1)  to obtain the desired α-keto acid (43).   
 
 21                                                 42                                                                            43 
40 
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4.1.2.3 Synthesis of the final target compound “Neolamellarin A” 
 
Once the key intermediates (20) and (41) were in hand, we next advanced to the 
challenging step of acylating the pyrrole (20).   
                              
             20                                                41                                                                44 
 
For this purpose, many attempts were made by acylating the acid chloride derivative 
of (41), which was prepared by using either thionyl chloride or oxalyl chloride in 
CH2Cl2, and using different bases such as triethyl amine, 2,6-lutidine, and sodium 
hydride. 
 
The preparation of the advanced intermediate (44) was finally achieved when 
acylation of the acid chloride of corresponding acid (41) with pyrrole (20) was carried 
out in DMF and molecular sieves, by using 2.2 eq of sodium hydride.  
 
The use of high temperature in the reaction was avoided, since it would have led to 
the decomposition of the labile acid chloride. 
The last step in our approach was the demethylation of the phenol groups, which 
was achieved by using BBr3 in CH2Cl2. 
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4.2 Synthesis of Aplysamine 6 
 In our approach towards the first total synthesis of Aplysamine 6, we explored many 
routes to prepare the key intermediates, amine (45) and acid (46), in order to build the 
best synthesis pathway for our compound. 
 
 
 
 
            11 
 
          
  45                                                                46 
In our search for the best synthetic pathway, we kept in mind the sensitivity and 
variety of functional groups present in the compound, which required further precautions 
to be applied in the reaction sequence to get the highly functionalized intermediates.  
 
Moreover, in our synthesis approach, we aimed to utilize very common starting 
materials available in-house that will facilitate the large-scale synthesis of this natural 
product as an anti-cancer agent. 
   
 
44 
 
 
 
4.2.1 Synthesis of (3-bromo-4-methoxyphenyl) acrylic acid 
Our synthetic strategy commenced with the synthesis of (3-bromo-4-
methoxyphenyl) acrylic acid (46). This was accomplished by the conversion of                   
p-anisaldehyde (21) to the known bromobenzaldehyde (47) that required an extended 
reaction time of 24 hours, stirring with Br2 in dichloromethane at 60◦C. In turn, bromo 
derivative (47) was subjected to Doebner–Knoevenagel condensation with malonic acid 
in the presence of pyridine and piperidine to afford cinnamic acid (46) with a 92% yield. 
 
 
 MeO
CHOBr
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4.2.2 Synthesis of the intermediate (45) 
Starting from 4-hydroxybenzaldehyde (48), three modifications  were necessary to 
access our target intermediate. These were: the formation of 2-aminoethyl group, the 
bomination of the aromatic compound, and the alkylation of the phenol group. 
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The synthesis of the intermediate (45) was started with bromination of the aromatic 
aldehyde (48) by stirring with Br2 in acetic acid at room temperature to get the             
2,6-dibromo aldehyde (49). This in turn was refluxed with nitromethane by using 
ammonium acetate as  the base to construct the intermediate  (49). 
 
                     
                                                  48                                                                     49 
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The alkylation of intermediate (50) to synthesis (51) proved to be unsuccessful. The 
reaction was carried out at elevated temperature by using different solvents such as THF 
or DMF, and NaH as a base. 
 
 
                              50                                                                                              51 
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The low reactivity of the phenol (50) was attributed to tautomeric quinone form 
(52) that depresses the reactivity of the phenol group towards the alkylation reaction.  
                        
                                          50                                                                          52 
Thus, we decided to alkylate the phenol group prior to the Henry reaction on the 
substrate (49). Alkylation of aldehyde (49) with 3-bromopropanol was carried out in 
THF by using potassium carbonate as a base  to get the alkylated product (53). This was 
then subjected to the Henry reaction under the same conditions as previously described.  
 
       
                                 49                                                                                   53 
 
                   53                                                                                                       54 
The reduction of alcohol (54) with LiAlH4 proved to be problematic, since it yielded 
a  mixture of reduced mono and di-debrominated products.    
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                            54                                                                                               55 
Consequently we changed our strategy by first synthesizing the amino moiety and 
then brominating the aromatic ring to get access to the intermediate (56). 
 
 
                                          
                                                                          56 
4.2.3 Synthesis of 4-(2-aminoethyl)-2,6-dibromophenol hydrobromide 
 
The synthesis of the phenol (56) began with reduction of aldehyde (48) with NaBH4 
to get the corresponding alcohol (57), which was heated with NaCN in DMF at 130◦C to 
get the intermediate (58).     
 
  
               48                                                          57                                                        58 
 
Hydrogenation of (58) in a mixture of EtOH and aqueous HCl produced the 
aminohydrochloride (59) with a 95% yield. 
 
48 
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The bromination of 4-hydroxyphenethylamine (59) was carried out in methanol at 
60◦C to produce the corresponding dibromide (60) as an off-white solid in a quantitative 
yield. 
 
4.2.4 Final steps of synthesis of Aplysamine 6 
 
Having the desired dibromide in hand, we next focused on the chemoselective 
acylation of dibromide (60). The acid (46) was transformed into the corresponding acid 
chloride (61) with the aid of thionyl chloride in THF. 
 
         
       46                                                                              61 
 
After evaporation of the solvents, a solution of acid chloride (61) in dry THF was 
added dropwise to a solution of dibromide (60) in THF at -10◦C using triethylamine as 
base. The reaction was unsuccessful due to the low yield (20%) of the desired amide 
HO
Br
Br
NH2.HBr
60 
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(62), along with the formation of a diacylated side-product which made column 
purification very tedious. 
 
 
                60                                                  61 
 
 The solubility of the dibromide (60) in THF at -10◦C was evidently very poor. 
Hence, in a second attempt, we added the acid chloride (61) to a solution of dibromide 
(60) in a mixture of THF and DMF (1:1) at 5 to 10◦C using 2,6-lutidine as the base. This 
gave the desired amide (62) cleanly with a 70% yield after column purification. 
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The amide (62) was alkylated by the action of excess 1,3-dibromopropane in DMF 
by using potassium carbonate as the base to give the compound (63) with an excellent 
yield (95%). 
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In turn, the compound (63) was reacted with excess ammonium hydroxide at 80◦C 
for 8 h in a sealed tube to produce aplysamine 6 (11) with an excellent yield (88%). The 
spectral data of our synthetic (11) coincided with those of the natural material (54). 
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In conclusion, we accomplished an efficient first total synthesis of Aplysamine 6, an 
inhibitor of isoprenylcysteine carboxy methyltransferase, with an overall 55% yield, 
starting from (46) and (60). 
 
Figure 24 outlines the complete synthesis scheme of Aplysamine 6 (59). 
 
 
 
                                                                                 Figure 24 
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CHAPTER 5  
EXPERIMENTAL WORK 
5.1 Instrumentation and Chemicals 
1H NMR and 13C NMR spectra were recorded on a JEOL Lambda 500 MHz 
spectrometer. Chemical shifts were reported in ppm (δ) relative to tetramethyl silane 
(TMS) by using (CDCl3) or (DMSO) as deuterated solvents. Multiplicities were reported 
as singlet (s), doublet (d), triplet (t), quartet (q) or multiplet (m), and coupling constants 
(J) were reported in hertz (Hz). IR Spectra were recorded on a NicoletTM 6700 FT-IR 
spectrometer from a thermo-electron by using a smart orbit for net samples, and they 
were reported in wave numbers (cm-1) (Spectral resolution, 4 cm-1; Number of scans, 4). 
Mass was determined by using Agilent 7000A Triple Quadrupole GC/MS. Elemental 
analysis was carried out on a EuroVector Elemental Analyzer Model EA3000. Al mps 
are uncorrected. 
 
Thin layer chromatography (TLC) was frequently used to monitor reactions and to 
give qualitative determination of sample purity. TLC analyses were performed on silica 
gel Merck 60 F254 plates, and spots were visualized under a spectroline UV lamp 
operating at short and long wavelength ranges. Visualization was improved by dipping 
plates into a phosphomolybdic acid solution, and then by drying in a blast of hot air. 
Purification of the products was carried out either by recrystallization or by flash column 
chromatography. The column was packed with Silica gel 100 from Fluka Chemie AG 
(Buchs, Switzerland). Ethyl acetate, petroleum ether (boiling fraction 60-80) and hexane 
were used as eluting solvents, in volume-by-volume ratios as stated. 
 
Chemicals were purchased from commercial sources, and they were used without 
any further purification unless otherwise specified. All solvents were of reagent grade, 
and dichloromethane was passed through alumina before use. Specially dried 
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(anhydrous) solvents were used where necessary. Glassware for moisture-sensitive 
reactions were oven dried at 120-140 °C for at least three hours and cooled in a 
desiccator prior to use. Some of the reactions were run in an inert atmosphere of 
nitrogen as stated. 
 
 
5.2 Synthesis of Neolamellarin A 
5.2.1.1 1,2-bis(4-methoxyphenyl)ethanone (Desoxyanisoin) (28) 
 
O
MeO OMe
 
 
To a mixture of 4-methoxyphenyl acetic acid (29) (0.6 g, 3.6 mmol), anisol (30) 
(0.46 g, 4.3 mmol), and 88–93% phosphoric acid (3.6 mmol) was rapidly added 
trifluoroacetic anhydride (12.1 mmol) with vigorous stirring at 25 ◦C. The mixture 
turned into a dark-colored solution with a vigorous exothermic reaction. The reaction 
mixture was stirred for 1 min at the same temperature, and ice-cold water (50 mL) was 
added. The off-white solid formed was filtered and washed with cold hexane (2 × 10 
mL) to obtain (28) as an off-white solid (0.89 g, 97%); mp: 105-106 ◦C; IR (Neat) νmax 
3000, 2952, 2902, 2832, 1673, 1597, 1505, 1455, 1410, 1327, 1240, 1166, 1106, 1023, 
983, 816 cm-1; 1H NMR (CDCl3): δ 3.78 (s, 3H), 3.86 (s, 3H), 4.18 (s, 2H), 6.84 (d, 2H, 
J = 8.85), 6.91 (d, 2H, J = 8.85), 7.16 (d, 2H, J = 8.55), 7.98 (d, 2H, J = 8.85). 13C NMR 
(CDCl3): δ 44.38, 55.24, 55.47, 113.76, 114.10, 126.93, 129.61, 130.37, 130.93, 132.32, 
158.44, 163.47, 196.60. MS (m/z): 256 (M+), 135, 121, 107, 92, 77, 63, 39.   
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5.2.1.2 3-Dimethylamino-1,2-bis-(4-methoxy-phenyl)-propenone (Vinylogous 
amide) (32) 
 
 
To a solution of α-aryl ketone (28) (0.67 g, 2.64 mmol) in toluene (14 mL) was 
added N,N-dimetylformamide dimethyl acetal (31) (1.4 mL, 10.56 mmol). The solution 
was heated overnight, and the solvent was removed under reduced pressure to yield a 
yellow solid, which was recrystallized by hexane/ethyl acetate (4:1) to afford vinylogous 
amide (32) (0.80 g, 98%) as a white solid; mp: 115-116 ◦C; IR (Neat) νmax 2930, 2833, 
1621, 1581, 1552, 1234, 1168, 1022, cm-1; 1H NMR (CDCl3): δ 2.74 (s, 6H), 3.79 (s, 
6H), 6.76 (d, 2H, J = 8.8), 6.80 (d, 2H, J = 8.85), 7.05 (d, 2H, J = 8.85), 7.36 (s, 1H), 
7.42 (d, 2H, J = 8.8). 13C NMR (CDCl3): δ 43.44, 55.18, 55.23, 111.29, 112.77, 113.16, 
129.96, 131, 133, 134.18, 153.09, 157.98, 160.57, 194.02. MS (m/z): 311 (M+), 294, 
135, 77.   
 
5.2.1.3  Dimethyl aminomalonate hydrochloride (34) 
 
 
 
To a mixture of dimethyl malonate (33) (4 g, 30.27 mmol) and acetic acid (5.18 ml, 
90.82 mmol) in water (7 ml) at 0 ◦C was added sodium nitrite (6.27 g, 90.82 mmol). The 
reaction mixture was stirred at room temperature for 3 h, water was added, and the 
mixture was extracted four times with diethyl ether. The combined ether layers were 
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cautiously treated with an equal volume of saturated aqueous sodium bicarbonate. Solid 
sodium bicarbonate was then added until the aqueous layer turned to yellow. The ether 
layer was separated and dried over sodium sulfate, and it was concentrated under 
reduced pressure to give crude oxime. Without any further purification, the crude oxime 
was dissolved in EtOH (31 ml) and transferred to a Parr pressure vessel which was 
charged with 10% palladium on charcoal (1.18 g) and methanolic-HCl (3N, 14 ml). The 
mixture was subjected to hydrogenation at (50 psi) for 12 h. The reaction mixture was 
filtered through a pad of Celite® and rinsed thoroughly with ethanol. Removal of the 
solvent under reduced pressure and reconcentration by CH2Cl2 gave pure (34) (5.06g, 
91%) as a green solid. mp: 132-134 ◦C; IR (Neat) νmax 3330 (br), 2959, 1739, 1435, 1268 
cm-1; 1H NMR (DMSO): δ 3.77 (s, 6H), 5.06 (s, 1H), 9.25 (s, 3H). 13C NMR (DMSO): δ 
53.76, 54.54, 164.17. MS (m/z): 147 (M+), 88, 60, 33.   
 
5.2.1.4 3,4-Bis-(4-methoxyphenyl)-1H-pyrrole-2-carboxylic acid methyl ester (36) 
 
 
 
To a solution of of vinylogous amide (32) (0.76 g, 2.44 mmol) in glacial acetic acid 
(4.5 ml) was added dimethyl aminomalonate hydrochloride (34) (0.456 g, 2.49 mmol). 
The resulting mixture was stirred at room temperature under N2 atmosphere for 1 h. The 
mixture was then diluted with (120 mL) of glacial acetic acid, and it was heated to reflux 
for 12 h. After the mixture was cooled to ambient temperature, the acetic acid was 
removed under reduced pressure. The residue was taken up in CH2Cl2 (50 mL) and 
washed with saturated sodium bicarbonate solution. The organic layer was washed with 
brine and dried over anhydrous Na2SO4. Final purification by column chromatography 
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using hexane/ethyl acetate (4 : 1 to 3 : 1) as eluent afforded pure (36) (0.51 g, 62%) as 
yellow needles. mp: 172 - 175 ◦C; IR (Neat) νmax 3301, 1669, 1439, 1378, 1242, 1169 
cm-1; 1H NMR (CDCl3): δ 3.73 (s, 3H), 3.76 (s, 3H), 3.82 (s, 3H), 6.75 (d, 2H, J = 8.85), 
6.85 (d, 2H, J = 8.85), 7.02 (s, 1H, obscured by the next peak), 7.03 (d, 2H, J = 8.55), 
7.19 (d, 2H, J = 8.55), 9.17 (br s, 1H). 13C NMR (CDCl3): δ 51.29, 55.14, 55.17, 113.08 
(2C), 113.64 (2C), 119.33, 120.07, 126.38, 126.45, 127.04, 129.04, 129.44 (2C), 131.85 
(2C), 157.99, 158.49, 161.57. MS (m/z): 337 (M+), 305, 262, 191, 152.   
 
5.2.1.5 3,4-Bis(4-methoxyphenyl)-1H-pyrrole-2-carboxylic acid (37) 
 
 
 
To a solution of the methyl ester (36) (0.62 g, 1.84 mmol) in a mixture of THF        
(8 ml), CH3OH (8 ml) and H2O (4 ml) was added LiOH (0.46 g, 11.05 mmol) and the 
mixture was stirred overnight at room temperature. The solvents were removed under 
reduced pressure, and the mixture was diluted with water and extracted with diethyl 
ether three times. The water layer was separated and acidified with HCl (1N) to pH 2 
and extracted with CHCl3 (3 × 20ml). The organic layer was dried over sodium sulfate 
and evaporated to give the desired product (37) (0.56 g, 95%) as a white solid.1H NMR 
(DMSO): δ 3.66 (s, 3H), 3.73 (s, 3H), 6.72 (d, 2H, J = 8.55), 6.81 (d, 2H, J = 8.55), 6.94 
(d, 2H, J = 8.25), 7.05 (d, 2H, J = 8.25), 7.08 (d, 1H, J = 2.75), 11.74 (s, 1H). 13C NMR 
(CDCl3): δ 54.89 (2C), 112.89 (2C), 113.57 (2C), 119.69, 120.56, 124.67, 127.29, 
127.43, 127.52, 128.84 (2C), 131.70 (2C), 157.29, 157.78, 162.01.  
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5.2.1.6 3,4-Bis(4-methoxyphenyl)-1H-pyrrole (20) 
 
N
H
MeO OMe
 
 
To a solution of the acid (37) (0.50 g, 1.55 mmol) in CH2Cl2 (30 ml) was added 
trifluoroacetic acid (6 ml) dropwise at 0 ◦C. The reaction mixture was stirred overnight at 
room temperature, and the solvent was evaporated under reduced pressure. Ethyl actate 
(50 ml) was added and successively washed with (1N) NaOH (20 ml) brine (20 ml), and 
then dried over sodium sulfate and evaporated. The product was purified by column 
chromatography using hexane/ethyl acetate (4 : 1 to 3 : 1) as eluent to give (20) (0.42 g, 
98%) as a yellow solid. mp: 104 - 106 ◦C; IR (Neat) νmax 3446, 2843, 1493, 1236, 1017, 
835, 786 cm-1; 1H NMR (CDCl3): δ 3.79 (s, 6H), 6.81 (d, 4H, J = 8.85), 6.84 (d, 2H, J = 
2.75), 7.19 (d, 4H, J = 8.85), 8.23 (br s, 1H). 13C NMR (CDCl3): δ 55.21, 113.64, 
116.75, 123.13, 128.41, 129.60, 157.84. MS (m/z): 279 (M+), 264, 204, 165.   
 
5.2.1.7 1,2-Bis(4-methoxyphenyl)ethane-1,2-dion (18) 
 
To the solution of p-anisaldehyde (21) (20 g, 146.9 mmol) in a mixture of 
EtOH:H2O (2:1, 150 ml) was added potassium cyanide (3.82 g, 58.76 mmol) and the 
reaction was refluxed overnight. The solution was poured over water and extracted with 
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dichloromethane, yielding the coupled α-hydroxyketone (17), which was dissolved in 
pyridine (125 ml) then H2O (75 ml) and 22.95 g CuSO4 was added. After refluxing for 
16 h, the reaction was cooled to room temperature and extracted with ethyl acetate. The 
organic layer was washed successively with HCl (1N) and brine. The solvent was 
reduced by evaporation, and it was left for crystallization to give (18) (26.20 g, 66%) as 
a pale yellow solid. mp: 124 – 127 ◦C; IR (Neat) νmax 2953, 2845, 1650, 1594, 1257, 
1010, 826 cm-1; 1H NMR (CDCl3): δ 3.89 (s, 6H), 6.96 (d, 4H, J = 8.85), 7.95 (d, 4H, J 
= 8.85). 13C NMR (CDCl3): δ 55.65, 114.29, 126.29, 132.39, 164.86, 193.51.  
 
5.2.1.8 2-acetamidoacetic acid (acetyl-glycine) (15) 
 
 
 
To the solution of glycine (14) (10 g, 133.33 mmol) in water (40 ml) was add acetic 
anhydride (27 ml) and the reaction mixture was stirred for 1 h at room temperature. The 
solvent was removed under reduced pressure to give (15) (15.3 g, 98 %) as white 
crystalline solid. mp: 204 - 206 ◦C; IR (Neat) νmax 3348, 1947, 1717, 1552, 1231, 990 
cm-1; 1H NMR (DMSO): δ 1.83 (s, 3H), 3.70 (d, 2H, J = 5.8), 8.16 (t, 1H), 12.50 (br s, 
1H). 13C NMR (DMSO): δ 22.34, 40.66, 169.70, 171.49.  
 
5.2.1.9 Methyl 2-acetamidoacetate (16) 
 
 
To the solution of N-acetyl-glycine (15) (4 g, 34.19 mmol) in methanol (24 ml) at 0 
◦C was added dropwise thionyl chloride (5 ml, 68.38 mmol). The reaction was stirred 
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overnight at room temperature, and the solvents were removed under reduced pressure to 
get (16) (4.39 g, 98 %) as white gum. IR (Neat) νmax 3349, 2341, 1719, 1383, 1231, 680 
cm-1; 1H NMR (DMSO): δ 1.83 (s, 3H), 3.59 (s, 3H), 3.78 (d, 2H, J = 5.5), 8.36 (s, 1H). 
13C NMR (DMSO): δ 22.23, 40.58, 51.66, 169.85, 170.52.  
 
5.2.1.10 Dimethyl N-acetyliminodiacetate (12) 
 
 
 
To a solution of methyl 2-acetamidoacetate (16) (3.2 g, 24.44 mmol) in DMF (112 
ml) was added NaH (0.76 g, 31.77 mmol) at 0 ◦C under nitrogen atmosphere. After 
stirring for half an hour, methyl 2-bromoacetate (5.61 g, 36.66 mmol) was added 
dropwise at 0 ◦C, followed by the addition of NaI (0.37 g, 2.44 mmol). Stirring was 
continued overnight at room temperature. The reaction mixture was diluted with water 
and extracted with diethyl ether (50 ml). The organic layer was washed with saturated 
sodium bicarbonate (20 ml) and brine (20 ml), and it was dried over sodium sulfate and 
evaporated to get the desired product (4.35 g, 88%) as thick yellow liquid. IR (Neat) νmax 
cm-1; 1H NMR (CD2Cl2): δ 1.47 (s, 3H), 3.54 (s, 4H), 3.59 (s, 6H). 13C NMR (DMSO): δ 
51.23, 54.19, 54.44, 171.02, 172.22.  
 
5.2.1.11 General procedure for the preparation of 3,4-Bis(4-methoxyphenyl)-1H-
pyrrole (20) by Hinsberg-type pyrrole synthesis 
 
Sodium (6 g) was dissolved in 28 mL of absolute methanol under an atmosphere of 
nitrogen in a 250 mL three-necked flask equipped with a nitrogen inlet and reflux 
condenser. The solution was cooled to room temperature, and 2.26 g of dimethyl N-
acetyliminodiacetate (12) (11.13 mmol) dissolved in 8 mL of dry methanol was added to 
the sodium methoxide solution while the mixture was being stirred by means of a 
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mechanical stirrer. Solid 3,3′-dimethoxybenzyl (18) (2 g, 7.42 mmol) was then added in 
fractions, and stirring was continued at room temperature until all of the 3,3′-
dimethoxybenzyl was dissolved. The reaction mixture was slowly heated to the boiling 
point, and then refluxed overnight. After removal of the solvent under reduced pressure, 
a mixture of H2O (28 ml) and THF (28 ml) was added followed by the addition of LiOH 
(1.87 g, 44.52 mmol). The reaction mixture was refluxed overnight. The reaction was 
diluted with water and extracted with diethyl ether to remove any traces of the starting 
materials. The water layer was acidified with HCl (1N) to pH 2 and extracted with 
CHCl3 (3 × 50 ml). The organic layer was dried over sodium sulfate and evaporated to 
get the diacid as a white needle which was used in the next step without any further 
purification.  The diacid was refluxed under nitrogen in 25 mL of freshly distilled 
ethanolamine for 4 h. The hot ethanolamine solution was then poured into 50 mL of cold 
water, and the aqueous solution was extracted four times with 25 mL of CH2Cl2. The 
combined organic layers were thoroughly washed with water in order to remove any 
trace of ethanolamine, and then dried over magnesium sulfate.  
 
5.2.1.12 2-Methyl-4-[4-(methoxy)benzylidene]-5(4H)-oxazolone (22) 
 
 
 
A mixture of p-anisaldehyde (21) (13.7 ml, 113 mmol), N- acetyl-glycine (15.87 g, 
135.6 mmol) and sodium acetate (12.05 g, 146.9 mmol) in acetic anhydride (14 ml, 
146.9 mmol) was stirred at reflux for 1 h. The reaction was quenched with ice (approx. 
50 mL) and vigorously stirred for 1 h in an ice bath to allow precipitation. Filtration of 
the solid afforded the title compound (22) (17.18 g, 70%) as a yellow solid. mp: 174 – 
177 ◦C; IR (Neat) νmax 1770, 1658, 1597, 1254 cm-1; 1H NMR (DMSO): δ 2.35 (s, 3H), 
3.82 (s, 3H), 7.05 (d, 2H, J = 8.85), 7.16 (s, 1H), 8.14 (d, 2H, J = 8.85). 13C NMR 
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(DMSO): δ 15.33, 55.52, 114.61 (2C), 125.87, 130.19, 134.19 (2CH,1C), 161.72, 
165.48, 167.66.  
 
5.2.1.13 3-(4-Methoxyphenyl)-2-oxopropionic acid [(4-methoxyphenyl) pyruvic 
acid] (23) 
 
 
A suspension of (31) (10 g, 46.04 mmol) in aq. HCl (3 M, 100 mL) was stirred at 
reflux for 3 h. The mixture was cooled to RT to allow crystallization, and then filtered to 
afford the title compound (23) (8.94 g, 95%) as an orange solid. IR (Neat) νmax 3440-
2935 (OH), 1719, 1602, 1509, 1243, 1169, 1024 cm-1; 1H NMR (DMSO): δ 3.74 (s, 3H), 
6.36 (s, 1H), 6.9 (d, 2H, J = 8.85), 7.69 (d, 2H, J = 8.85), 8.95 (br s, 1H). 13C NMR 
(DMSO): δ 20.89, 109.71, 128.92, 129.22, 132.1, 136.57, 141.10, 166.38.  
 
5.2.1.14 Methyl 3-(4-methoxyphenyl)-2-oxopropanoate [3-(4-hydroxyphenyl) 
pyruvat] (24) 
 
 
To a solution of (4-methoxyphenyl) pyruvic acid (23) (4.44 g, 22.88 mmol) in DMF 
(150 ml) at 0 ºC was added DBU (3.42 ml, 22.88 mmol) and MeI (5.7 ml, 91.52mmol). 
The mixture was stirred for 4.5 h at the same temperature, acidified with 1 M HCl and 
extracted with diethyl ether (2 x 50 ml). The combined organic layers were washed with 
brine, dried over MgSO4, and evaporated to dryness to give the title compound (24) 
(4.29 g, 90%) as yellow oil. 1H NMR (DMSO): δ 3.74 (s, 3H), 3.76 (s, 3H), 6.39 (s, 1H), 
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6.91 (d, 2H, J = 8.25), 7.71 (d, 2H, J = 8.25), 9.26 (s, 1H). 
 
5.2.1.15 General procedure for the coupling reaction of arylpyrovic ester with 
ammonia 
To a solution of methyl 3-(4-hydroxyphenyl) pyruvate (24) (0.65 g, 3.32 mmol) in 
anhydrous MeOH (120 ml) was added NaOMe (1.62 g, 30 mmol) under N2 atmosphere. 
The mixture was stirred for 15 min and then treated dropwise with a solution of I2 (0.42 
g, 1.66 mmol) in MeOH (100 mL). After stirring at room temperature for 45 min., concd 
aq ammonia (1 ml) was added, and the stirring continued for 30 min. The reaction was 
completed by heating the solution to 60 ◦C in a sealed tube for 1h followed by refluxing 
for 4 h. After reducing the volume to 100 ml by evaporation, 15 ml of THF was added, 
followed by the addition of LiOH (0.5 g, 12 mmol) and refluxed overnight. The reaction 
mixture was diluted with water and extracted with diethyl ether to remove any traces of 
starting materials. The water layer was separated and acidified with HCl (1N) to pH 2 
and extracted with CHCl3 three times. The organic layer was dried over sodium sulfate 
and evaporated to give white needles which were used in the following step without any 
further purification.  The resultant acid was refluxed under nitrogen in 25 mL of freshly 
distilled ethanolamine for 4 h. The hot ethanolamine solution was then poured into 50 
mL of cold water, and the aqueous solution was extracted four times with 25 mL of 
CH2Cl2. The combined organic layers were thoroughly washed with water in order to 
remove any trace of ethanolamine, and then dried over magnesium sulfate.  
 
5.2.1.16  (4-methoxyphenyl) methanol (38) 
 
 
 
To a solution of p-anisaldehyde (21) (6 g, 44.07 mmol) in a mixture of THF (24 ml) 
and H2O (36 ml) was added NaBH4 (1.68 g, 44.07 mmol) portionwise and the reaction 
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mixture was stirred for 0.5 h at room temperature. The reaction mixture was extracted 
with EtOAc (50 ml) and the organic layer was washed successively with (1N) HCl (50 
ml) and brine. Evaporation of the solvent under reduced pressure afforded (38) (5.79 g, 
95%) as clear liquid. IR (Neat) νmax 3322, 2935, 2835, 1609, 1511, 1242, 1028, 813 cm-
1; 1H NMR (DMSO): δ 3.72 (s, 3H), 4.41 (d, 2H, J = 5.5), 5.06 (t, 1H), 6.87 (d, 2H, J = 
8.55), 7.22 (d, 2H, J = 8.55). 13C NMR (DMSO): δ 55.01, 62.59, 113.46, 127.95, 134.53, 
158.18.  
 
5.2.1.17 4-methoxyphenylacetic acid (41) 
 
 
 
To a solution of (4-methoxyphenyl) methanol (38) (5.79 g, 41.91 mmol) in 
dichloromethane (60 ml) at 0◦C was added thionyl chloride (7.07 ml, 96.95 mmol) 
dropwise. The mixture was stirred overnight at room temperature, and washed with 
water (50 ml) and dried over sodium sulfate. The solvent was evaporated under reduced 
pressure at 30 ◦C to afford corresponding benzyl chloride as a clear liquid, which was 
used in the next step without any further purification. After dissolving the chloride in 
DMF (60 ml) NaCN (2.37 g, 48.47 mmol) was added, and the reaction was stirred 
overnight at room temperature. The reaction mixture was extracted in ethyl acetate (70 
ml) and washed with H2O (30 ml), (1N) HCl (30 ml) and brine. After drying over 
sodium sulfate, the solvent was removed under reduced pressure to obtain the cyanide 
derivative, which was dissolved in methanol (40 ml) and treated with (4 N) NaOH (40 
ml). The reaction mixture was refluxed overnight, and  extracted with diethyl ether to 
remove any traces of the starting materials. The water layer was acidified with (1N) HCl 
to pH 2, and the solid formed was filtered and then washed with H2O to  afford the title 
compound (41) (5.13 g, 70 %) as white crystals. mp: 78 – 80 ◦C. IR (Neat) νmax 2942, 
2739, 1692, 1412, 1236, 1021  cm-1.  1H NMR (DMSO): δ 3.47 (s, 2H), 3.71 (s, 3H), 
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6.85 (d, 2H, J = 8.55), 7.15 (d, 2H, J = 8.55), 12.24 (br s, 1H).13C NMR (DMSO): 39.80, 
55.03, 113.68, 126.96, 130.39, 158.04, 173.03.  
 
5.2.1.18 1-(3,4-bis(4-methoxyphenyl)-1H-pyrrol-1-yl)-2-(4-methoxyphenyl) 
ethanone (44) 
 
 
 
To a solution of 4-methoxyphenylacetic acid (41) (65.2 mg, 0.39 mmol) in dry 
dichloromethane (4 mL) under N2 atmosphere at 0 ◦C was added oxalyl chloride  (58.8 
mg, 0.46 mmol) dropwise, followed by the addition of 2 drops of DMF. The reaction 
mixture was stirred at the same temperature for 15 min, and then at room temperature 
for 2 h, and evaporated to dryness. In another flask, a solution of 3,4-Bis(4-
methoxyphenyl)-1H-pyrrole (20) (54.6 mg, 0.19 mmol) in DMF (5 ml) was cooled to 0 - 
5 ◦C, followed by the portionwise addition of NaH (11.8 mg, 0.49 mmol) and 0.5 g of 
oven-dried molecular sieves. After being stirred for 0.5 h at room temperature, the acid 
chloride solution (41) in THF (0.5 ml) at 0 ◦C was added dropwise to the reaction 
mixture over the course of 15 min. The reaction mixture was stirred overnight at room 
temperature, then diluted with ethyl acetate and washed successively with sat. NaHCO3 
and brine. The organic layer was dried over sodium sulfate and purified by column 
chromatography eluting with ethyl acetate:hexanes (1:5), to afford the title compound 
(44) (32.49 mg, 40%) as yellow liquid. IR (Neat) νmax 3347, 2959, 1669, 1602, 1510, 
1250, 1024, 792 cm-1; 1H NMR (CDCl3): δ 3.8 (s, 9H), 4.12 (s, 2H), 6.82 (d, 4H, J = 
8.85), 6.90 (d, 2H, J = 8.85), 7.15 (d, 4H, J = 8.85), 7.19 (d, 2H, J = 8.85), 7.39 (br s, 
2H).13C NMR (CDCl3): 40.54, 55.23, 55.30, 113.63, 113.76, 114.38, 116.74, 117.21, 
125.07, 126.36, 129.60, 129.65, 130.23, 158.68. MS (m/z): 427 (M+), 295, 135, 77. 
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5.3 Synthesis of Aplysamine 6 
5.3.1.1 2-(4-hydroxyphenyl) acetonitrile (58) 
 
                  
 
To a solution of 4-(hydroxymethyl) phenol (57) (4 g, 32.22 mmol) in DMF (100 ml) 
was added NaCN (1.89 g, 38.66 mmol). The mixture was heated at 130 ◦C for 24 h. The 
reaction mixture was extracted in ethyl acetate (150 ml) and washed with H2O, (1N) HCl 
(Caution-HCN), H2O, and brine. After drying the organic layer over anhydrous sodium 
sulfate, the solvent was removed under reduced pressure to get (58) (2.79 g, 65%) as 
white solid. 1H NMR (CDCl3): δ 3.68 (s, 2H), 5.61 (br s, 1H), 6.84 (d, 2H, J = 8.55), 
7.18 (d, 2H, J = 8.55). 13C NMR (CDCl3): δ 22.81, 116 (2CH), 118.23, 121.59, 129.24 
(2CH), 155.61.  
 
5.3.1.2 4-hydroxyphenethylamine (59) 
 
 
 
 
To a solution of (58) (2.79 g, 20.95 mmol) in a mixture of EtOH (30 ml) and (3N) 
methanolic-HCl (14 ml) in a Parr pressure vessel was added 10% palladium on charcoal 
(0.4 g). The mixture was subjected to hydrogenation at 50 psi for 12 h. The reaction 
mixture was filtered through a pad of Celite® and rinsed thoroughly with ethanol. 
Removal of the solvent under reduced pressure gave pure (59) (3.46 g, 95%) as an off-
white solid; 1H NMR (DMSO): δ 2.76 (t, 2H), 2.91 (m, 2H), 6.71 (d, 2H, J = 8.25), 7.01 
66 
 
 
 
(d, 2H, J = 8.25), 8.13 (s, 3H), 9.39 (s, 1H). 13C NMR (DMSO): δ 32.11, 40.22, 115.35, 
127.26, 129.49, 156.15.  
 
5.3.1.3 4-(2-aminoethyl)-2,6-dibromophenol hydrobromide (60) 
 
HO
Br
Br
NH2.HBr
 
 
To a solution of 4-hydroxyphenethylamine (59) (3.40 g, 19.58 mmol) in methanol 
(50 ml) was added Br2 (2.21 ml, 43.08 mmol). The reaction mixture was stirred at    
60◦C for 12 h. The solvent was removed under reduced pressure to obtain the title 
compound (60) (7.21 g, 98 %) as an off white solid. 1H NMR (DMSO): δ 2.75 (t, 2H), 
3.01 (t, 2H), 7.45 (s, 2H), 7.76 (s, 3H), 9.95 (br s, 1H). 13C NMR (DMSO): δ 31.39, 
39.90, 112.11, 131.78, 132.75 (2CH), 149.72.  
 
5.3.1.4 3-bromo-4-methoxybenzaldehyde (47) 
 
 
 
To a solution of p-anisaldehyde (21) (2 g, 14.69 mmol) in dichloromethane (25 ml) 
was added Br2 (0.9 ml, 17.63 mmol) dropwise. The reaction mixture was stirred at 60 ◦C 
for 24 h. The mixture was diluted with CH2Cl2 (30 ml) and washed with water (20 ml), 
sat. NaHCO3 (20 ml) and brine (20 ml). The organic layer was dried over anhydrous 
sodium sulfate, and the solvent was evaporated under reduced pressure to get (47) (2.53 
g, 80 %) as white solid. 1H NMR (DMSO): δ 3.94 (s, 3H), 7.28 (d, 1H, J = 8.55), 7.90 
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(dd, 1H, J = 8.55, 2.1), 8.06 (d, 1H, J = 2.1), 9.83 (s, 1H). 13C NMR (DMSO): δ 57.07, 
111.57, 112.99, 130.69, 131.54, 133.98, 160.25, 190.78.  
 
5.3.1.5 (3-bromo-4-methoxyphenyl) acrylic acid (46) 
 
 
 
To a solution of 3-bromo-4-methoxybenzaldehyde (47) (1.86 g, 8.63 mmol) in a 
mixture of pyridine (20 ml) and piperidine (2.84 ml, 28.78 mmol) was added malonic 
acid (0.65 g, 7.19 mmol). The reaction mixture was heated at 120 ◦C overnight. After 
cooling to ambient temperature, H2O (15 ml) was added, followed by the addition of 
(1N) NaOH to make pH 10. The mixture was extracted with diethyl ether (20 ml × 3) 
and the aqueous layer was acidified with 2N HCl to pH 2 and extracted with ethyl 
acetate (25 ml × 2). The combined organic layers were dried over anhydrous sodium 
sulfate and evaporated under reduced pressure to give (46) (2.04 g, 92 %) as light yellow 
solid. 1H NMR (DMSO): δ 3.87 (s, 3H), 6.44 (d, 1H, J = 15.85), 7.12 (d, 1H, J = 8.55), 
7.49 (d, 1H, H = 15.85), 7.68 (dd, 1H, J = 8.55, 2.45), 7.94 (d, 1H, J = 2.45). 13C NMR 
(DMSO): δ 56.62, 111.34, 112.93, 118.20, 128.52, 129.55, 132.65, 142.52, 156.93, 
167.83. 
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5.3.1.6  (E)-3-(3-bromo-4-methoxyphenyl)-N-(3,5-dibromo-4-hydroxyphenethyl) 
acrylamide (62) 
 
 
To a solution of cinnamic acid (46)  (0.3 g, 1.17 mmol) in dry THF (10 mL) at 0 ◦C 
was added thionyl chloride (0.42 g, 3.51 mmol) dropwise, and the reaction was stirred 
overnight at room temperature. The solvent was evaporated under reduced pressure, and 
the acid chloride (61) was kept under high vacuum for 1 h. In another flask, a solution of 
amine compound (60) (0.45 g, 1.29 mmol) in a mixture of dry THF (15 mL) and DMF 
(15 mL) was cooled to between 5 and 10 ◦C, followed by the dropwise addition of 2,6-
lutidine     (0.55 g, 5.16 mmol). After being stirred for 0.5 h, a solution of (61) in dry 
THF (6 mL) was added dropwise to the reaction mixture over the course of 15 min. The 
reaction mixture was stirred for 1 h at the same temperature. Then it was diluted with 
ethyl acetate and washed successively with 2 N HCl, brine, sat. NaHCO3, and brine and 
dried over sodium sulfate. Column chromatography of the dark orange oily material, 
eluted with ethyl acetate:hexanes (4:6), afforded amide (62) (0.43 g, 70%) as a white 
crystalline solid. mp: 172–173 ◦C. Anal. Calcd for C18H16Br3NO3 requires C, 40.48; H, 
3.02; N, 2.62. Found: C, 40.42; H, 3.06; N, 2.59; IR (KBr) νmax 3415, 3250, 1675, 1530, 
1485, 1245, 1150 cm-1; 1H NMR (DMSO-d6; 500 MHz): δ 2.66 (t, 2H, J = 7), 3.36 
(CH2NHCO-; obscured by the DMSO signal), 3.86 (s, 3H), 6.50 (d, 1H, J = 15.8), 7.13 
(d, 1H, J = 8.5 Hz), 7.30 (d, 1H, J = 15.8), 7.39 (s, 2H), 7.54 (dd, 1H, J = 8.5, 2.1 Hz), 
7.77 (d, 1H, J = 2.1), 8.02 (t; 1H). 13C NMR (DMSO-d6; 125.7 MHz): δ 33.3 (CH2), 
39.6 (CH2; obscured by DMSO peak), 56.3 (OCH3), 111.0 (C), 112.8 (CH), 119.2 (2C), 
121.2 (CH), 128.4 (CH), 129.1 (C), 131.6 (CH), 131.5 (C), 132.2 (2CH), 136.7 (CH), 
149.0 (C), 156.1 (C), 164.9 (C). 
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5.3.1.7 Aplysamine 6 (11) 
 
 
 
To a solution of (62) (0.4 g, 0.75 mmol) in DMF (10 ml) was added sodium 
carbonate (0.2 g, 1.87 mmol) followed by the dropwise addition of  1,3-dibromopropane 
(0.23 g, 1.13 mmol). The reaction mixture was stirred at room temperature for 20 h. 
Water was added to the reaction, and the mixture extracted with ethyl acetate (50 ml). 
The organic layer was washed with 1N HCl and brine, and then dried over anhydrous 
sodium sulfate. Solvent was removed under reduced pressure to get the alkylated 
product as light yellow thick oil, which was purified by column chromatography eluting 
with EtOAc : Hex (2:4) and changing to (3:7) to get the title compound as colorless 
thick oil. The bromide intermediate  was dissolved in THF (10 ml) and treated with an 
excess of NH4OH (5 ml). The reaction was stirred in sealed tube at 80 ◦C for 8 h. Water 
was added and the mixture was extracted with ethyl acetate, and the organic layer was 
washed with (1N) HCl and brine. After drying over anhydrous sodium sulfate the 
product was purified by column chromatography using hexane/ethyl acetate (5: 1 to 4 : 
1) as eluent to give pure (11) (0.39 g, 88 %) as colorless gum. Anal. Calcd for 
C21H23Br3N2O3 requires C, 42.67; H, 3.92; N, 4.74. Found: C, 42.59; H, 3.98; N, 4.66. 
IR (KBr) νmax 3410, 3273, 3061, 1682, 1540, 1497, 1458, 1260, 1201, 1138, 1050 cm-1. 
1H NMR (DMSO-d6; 500 MHz): δ 1.92 (m, 2H), 2.60 (t, 2H, J = 6.4 Hz), 2.72 (m, 2H, J 
= 6.4 Hz), 3.39 (m, 2H, J = 6.4 Hz), 3.85 (s, 3H), 3.96 (t, 2H, J = 6.5 Hz), 6.50 (d, 1H, J 
= 15.6 Hz), 7.12 (d, 1H, J = 8.5 Hz), 7.32 (d, 1H, J = 15.6 Hz), 7.49 (s, 2H), 7.53 (dd, 
1H, J = 8.5, 1.8 Hz), 7.76 (d, 1H; J = 1.8 Hz), 8.05 (t, 1H). 13C NMR (DMSO-d6; 125.7 
MHz): δ 28.9 (CH2), 33.5 (CH2), 39.6 (CH2; obscured by the DMSO signal), 45.5 (CH2), 
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56.4 (OCH3), 71.4 (CH2), 111.1 (C), 112.9 (CH), 117.3 (2C), 121.1 (CH), 128.5 (CH), 
129.0 (C), 131.6 (CH), 132.9 (2 CH), 136.9 (CH), 139.0 (C), 150.7 (C), 156.1 (C), 165.0 
(C). 
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